Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3927]

Diagnosis while pregnant should not lead to treatment delay or pregnancy...

Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium

Diagnosis while pregnant should not lead to treatment delay or pregnancy termination ( Prof Frederic Amant - Katholieke Universiteit Leuven, Leuven, Belgium )

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia

Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany

DDFMISO trial confirms significant negative prognostic value of tumour hypoxia ( Prof Michael Baumann - University Hospital Carl Gustav Carus, Dresden, Germany )

'Survivor passport' for survivors of childhood leukaemia

Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel...

'Survivor passport' for survivors of childhood leukaemia ( Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany )

Progression of childhood cancers in Europe

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Progression of childhood cancers in Europe ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Expanding access to crizotinib using a biomarker-driven approach

Prof Gilles Vassal - University Paris-Sud, Orsay, France

Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )

Latest in lung cancer from ECC 2015

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany

Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer:...

Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK

ADT plus docetaxel or bisphosphonates in hormone sensitive prostate cancer: Systemic review ( Dr Claire Vale - MRC Clinical Trials Unit at UCL, London, UK )

Economics of radiotherapy and radiotherapy boost for high grade invasive breast...

Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands

Economics of radiotherapy and radiotherapy boost for high grade invasive breast cancer ( Prof Philip Poortmans - University Medical Center, Nijmegen, The Netherlands )

EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors...

Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland

EORTC ‘boost no-boost’ trial 20-year follow up: Impact of pathological factors on long-term local control ( Dr Conny Vrieling - Clinique des Grangettes, Geneva, Switzerland )

Melanoma immunotherapy latest and TVEC plus pembrolizumab

Dr Georgina Long - University of Sydney, Sydney, Australia

Melanoma immunotherapy latest and TVEC plus pembrolizumab ( Dr Georgina Long - University of Sydney, Sydney, Australia )

More from ecancer